在固体瘤中,PIM1激酶及其多种基质
Rituparna Choudhury1, Chandan Kumar Bahadi1, Ipsa Pratibimbita Ray1
1School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT) Deemed-to-Be-University, Bhubaneswar, 751024, India.
Cell communication and signaling : CCS
|November 2, 2024
概括
在癌症中至关重要的PIM1激酶促进瘤生长和存活. 抑制PIM1激酶显示出作为癌症治疗的希望,在临床试验中的新药.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 皮姆激酶 (PIM1,PIM2,PIM3) 是一种对细胞生长,免疫调节和癌症发展至关重要的血清蛋白/氨酸蛋白激酶.
- 在各种癌症中,PIM1激酶经常过度表达,导致瘤细胞存活,增殖,迁移和衰老.
- 皮姆1的致癌作用得到了体外和体内研究的支持,将其与瘤进展,转移和化疗耐药性联系起来.
研究的目的:
- 审查不同癌症中PIM1激酶的分子机制.
- 探索PIM1抑制在癌症治疗中的治疗潜力.
- 总结一下PIM1激酶抑制剂的最新进展.
主要方法:
- 关于PIM1激酶通路和功能的文献综述.
- 对PIM1抑制剂的体外,体内和临床试验数据的分析.
- 对新型PIM1激酶抑制剂化合物的检查.
主要成果:
- PIM1激酶与各种基质相互作用,影响各种癌症的结果.
- 抑制PIM1是一种正在发展中的癌症治疗策略,临床前和早期临床数据显示有前途.
- 新型PIM1抑制剂在临床前研究中表现出有效性和良好的毒性概况.
结论:
- 在瘤学中,PIM1激酶是重要的治疗点.
- 皮姆1激酶抑制剂代表了癌症治疗的有希望的途径.
- 目前正在进行的临床试验正在评估新型PIM1抑制剂的疗效.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K


